Concurrence of primary hyperparathyroidism and metastatic breast carcinoma affected a parathyroid gland.

OBJECTIVE Involvement of the parathyroid glands by metastatic tumor is rare. Breast is 1 of the primary sites in metastatic cancers. We introduce a rare case of metastatic breast carcinoma affecting a parathyroid gland, which was clinically combined with parathyroid gland hyperplasia. CASE REPORT A 65-year-old woman was referred due to hypercalcemia and constipation. The patient had a history of left breast carcinoma. She was admitted to the hospital because of the recent discovery of hypercalcemia and elevation of PTH. A Tc99m-sestamibi scan showed retained uptake in the right thyroid and in the lower pole of the left thyroid gland. Aspiration biopsy results revealed that the nodule in the posterior portion of the right thyroid was metastatic breast cancer and the nodule in the left thyroid gland was the hyperplastic parathyroid gland. CONCLUSION This case illustrates that hyperparathyroidism caused by parathyroid hyperplasia was concurrent with metastatic breast cancer to a parathyroid gland without disseminated systemic metastasis. Although this case is very uncommon and it is not clear whether there is a relationship between breast cancer and primary hyperparathyroidism, that possibility should always be considered as the cause of hypercalcemia in patients with breast cancer.

[1]  N. Flaris,et al.  Parathyroid involvement in thyroid cancer: an unforeseen event , 2012, World Journal of Surgical Oncology.

[2]  S. Cerovic,et al.  Correlation of subtraction parathyroid scintigraphy with weight, pathohistologic finding and oxyphil cell content of parathyroid glands in parathyroid hyperplasia. , 2012, Vojnosanitetski pregled.

[3]  F. Fulciniti,et al.  Metastatic breast carcinoma to parathyroid adenoma on fine needle cytology sample: Report of a case , 2011, Diagnostic cytopathology.

[4]  A. Egashira,et al.  Immunohistochemical expression of epidermal growth factor receptor in breast cancer , 2011, Breast cancer.

[5]  A. D'cruz,et al.  Hypercalcemia and treated breast cancers: the diagnostic dilemma. , 2009, Journal of Cancer Research and Therapeutics.

[6]  Brian J Welch,et al.  Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer. , 2008, Southern medical journal.

[7]  Inga-Lena Nilsson,et al.  The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. , 2007, Endocrine-related cancer.

[8]  C. Russell,et al.  Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland , 2006, Journal of Clinical Pathology.

[9]  A. F. Stewart.  Hypercalcemia Associated with Cancer , 2005 .

[10]  A. F. Stewart.  Clinical practice. Hypercalcemia associated with cancer. , 2005, The New England journal of medicine.

[11]  K. Michels,et al.  Hyperparathyroidism and subsequent incidence of breast cancer , 2004, International journal of cancer.

[12]  C. Marcocci,et al.  Epidemiology of primary hyperparathyroidism in Europe. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  L. Brinton,et al.  Hyperparathyroidism and subsequent cancer risk in Denmark , 2002, Cancer.

[14]  C. Marcocci,et al.  Increased prevalence of primary hyperparathyroidism in treated breast cancer , 2001, Journal of endocrinological investigation.

[15]  P. Gattuso,et al.  Neoplasms metastatic to parathyroid glands. , 1988, Southern medical journal.

[16]  J. Knol,et al.  Malignancy and concomitant primary hyperparathyroidism , 1988, Journal of surgical oncology.

[17]  T. Watanabe,et al.  A case of advanced breast cancer associated with hypocalcemia. , 1983, Japanese journal of clinical oncology.

[18]  B. M. Black,et al.  Primary hyperparathyroidism and metastatic breast carcinoma: A case in which breast carcinoma metastasized to a parathyroid adenoma , 1958, Cancer.